Pulmonary

Apr 2, 2002

Simplified Practical Chart of Pulmonary
Vascular Segmental Anatomy.

Cote rendition of a practical pulmonary segmental chart to be used for the interpretation of V/Q lung scans.

[Table of Content]

Anchor Point Tracking, designed for use with the new RefleXion X2 platform, underpins SCINTIX therapy with higher fidelity biologic data.

RefleXion Medical submits FDA 510(k) for Anchor Point tumor tracking

June 30, 2026

Business Deal Corporate 400

Ratio Therapeutics signs Ac-225 supply agreement with PanTera

June 30, 2026

Advancing molecular imaging together

Advancing molecular imaging together

May 24, 2026

Nuclearmedicine

AdvanCell establishes U.S. headquarters, manufacturing facility

June 22, 2026

RefleXion Medical submits FDA 510(k) for Anchor Point tumor tracking

By AuntMinnie.com staff writers

RefleXion Medical is seeking FDA clearance for the company's Anchor Point Tracking tech for radiotherapy use.

June 30, 2026

Anchor Point Tracking, designed for use with the new RefleXion X2 platform, underpins SCINTIX therapy with higher fidelity biologic data.

Ratio Therapeutics signs Ac-225 supply agreement with PanTera

By AuntMinnie.com staff writers

Deal will support Ratio's alpha therapy programs.

June 30, 2026

Business Deal Corporate 400

SNMMI mourns passing of Twyla Bartel

By AuntMinnie.com staff writers

The SNMMI is mourning the passing of one of its leading members.

June 23, 2026

Twyla Bartel, DO

AdvanCell establishes U.S. headquarters, manufacturing facility

By AuntMinnie.com staff writers

The Andover site will support development and future commercialization of ADVC001.

June 22, 2026

Nuclearmedicine

New immuno-PET tracer shows promise in prostate cancer

Compared to conventional imaging, Zr-89 DFO-YS5 PET identified additional lesions.

June 15, 2026

A 74-year-old patient with metastatic prostate cancer with a positive left iliac wing lesion (SUVmax of 35.02) seen on (A) Zr-89 DFO-YS5 PET maximum projection image (MIP) and (B) PET/CT (red arrows). The lesion was graded 5 on PET but was not visible on CT (D) or (D) technitium-99 MDP bone scan.

What side effects do patients report after Pluvicto therapy?

Fatigue, pain flare, nausea, and urinary symptoms are among the most commonly reported immediate side effects of Pluvicto therapy.

June 5, 2026

Post-Pluvicto SPECT/CT with axial fused images of sacrum and sagittal maximum intensity projection of one of the patients who complained of increasing pain in the sacral region (arrows) post therapy.

SNMMI ShowCast Roundup

Science was the star in Los Angeles at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 5, 2026

Radiopharmaceutical manufacturers report uneven FDA inspections

RMTA lays out radiopharmaceutical regulatory and payment policy issues.

June 4, 2026

Lab Equipment Drug Manufacturing

Alpha Tau, Tolmar strike $196M deal to commercialize Alpha DaRT

By AuntMinnie.com staff writers

Tolmar will make a $20 million equity investment in Alpha Tau at closing and contribute $15 million toward construction of a new U.S. production facility.

June 3, 2026

SNMMI awards Martin Pomper 2026 Benedict Cassen Prize

By AuntMinnie.com staff writers

The SNMMI has awarded Martin Pomper, MD, PhD, the Benedict Cassen Prize for his contributions toward nuclear medicine research.

June 1, 2026

Martin Pomper, MD, PhD

ASCO: Lu-177 edotreotide yields sustained quality-of-life gains

By Erik L. Ridley

A poster presentation at ASCO 2026 highlighted quantifiable benefits for patients receiving the radiopharmaceutical treatment for GEP-NETs.

May 31, 2026

Archeus doses first patient in phase I RPT trial

By AuntMinnie.com staff writers

In preclinical work, Y-90 ARC-706 demonstrated tumor-selective uptake across multiple ICI-treated cancers.

May 27, 2026

Page 1 of 443